Pursuant to Regulation 30 and other applicable provisions of the Listing Regulations, Omkar Pharmachem has informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held today Saturday, January 18th, 2025, approved the appointment of Pankaj Mahadeo Singh as Company Secretary (CS) and Compliance Officer (CS) with effect from January 18th, 2025. The required details pursuant to SEBI Listing Regulations are provided in the Annexure to this letter.
The above information is a part of company’s filings submitted to BSE.